globoid cell leukodystrophy

Also found in: Dictionary, Acronyms, Encyclopedia.

glo·boid cell leu·ko·dys·tro·phy

a metabolic disorder of infancy or early childhood characterized by spasticity, seizures, and rapidly progressive cerebral degeneration, massive loss of myelin, severe astrocytic gliosis, and infiltration of the white matter with characteristic multinucleate globoid cells; metabolically there is gross deficiency of lysosomal cerebrosidase (galactosylceramide β-galactosidase); autosomal recessive inheritance, caused by mutation in the gene encoding glycosylceramidase (GALC) on 14q.
Farlex Partner Medical Dictionary © Farlex 2012

globoid cell leukodystrophy

Krabbe's disease Neurology An AR defect in sphingolipid metabolism due to galatocerebroside β-galactosidase deficiency, resulting in in utero demyelinization, and death in early infancy Clinical Spastic paralysis, seizures, pyrexia, vomiting, cortical blindness, deafness, dysphagia, pseudobulbar palsy, quadriplegia, mental deterioration Management CNS disease may be reversed by allogeneic hematopoietic stem cell transplantation. Cf Leukodystrophy.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.

globoid cell leukodystrophy

An autosomal recessive disease caused by a deficiency of the lysosomal enzyme galactocerebrosidase. It features failure of myelination and demyelination in the entire nervous system and, in the infantile form, death usually before two years of age. Injection of donor umbilical cord blood before the onset of symptoms has been found helpful.
Collins Dictionary of Medicine © Robert M. Youngson 2004, 2005


Knud Haraldsen, Danish neurologist, 1885-1961.
Christensen-Krabbe disease - see under Christensen
Krabbe disease - a metabolic disorder of infancy. Synonym(s): globoid cell leukodystrophy
Medical Eponyms © Farlex 2012
References in periodicals archive ?
Krabbe's globoid cell leukodystrophy: Deficiency of galactocerebro-sidase in serum, leukocytes and fibroblasts.
Bone marrow transplantation for globoid cell leukodystrophy, adrenoleukodystrophy, metachromatic leukodystrophy, and Hurler syndrome.
The ongoing Phase 2 study in inherited metabolic disorders aims to enroll 12 patients with cerebral adrenoleukodystrophy, metachromatic leukodystrophy or globoid cell leukodystrophy, and previously also enrolled patients with Hurler's syndrome.